Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.

Low adherence to febrile neutropaenia guidelines leads to hospitalization, over-prescription

07 Oct 2020

A recent study has found low adherence to the febrile neutropaenia guidelines, which results in unnecessary hospital admissions of low-risk patients and over-prescription of empirical vancomycin.

The authors conducted a retrospective observational cohort study at a 60,000-visit emergency department at an academically affiliated tertiary referral hospital to assess guideline adherence and clinical outcomes associated with the management of febrile neutropenia patients. They identified patients as either low- or high-risk using the guideline-recommended Multinational Association for Supportive Care in Cancer score.

Guideline adherence referred to hospital admission and intravenous antimicrobial therapy for high-risk patients and discharge home with oral antimicrobial therapy for low-risk patients.

A total of 237 patients were included, of whom 94 (39.7 percent) were low-risk and 143 (60.3 percent) high-risk. The proportion of cases in which the management was concordant with applicable febrile neutropaenia guidelines—the primary outcome—was 96.8 percent in high-risk patients and only 0.4 percent low-risk patients.

The secondary outcome of mean hospital length of stay was 5±5.0 days in the low-risk group and 7.2±7.3 in the high-risk group. For the other secondary outcomes, Clostridium difficile occurred in 15 (10.3 percent) adherent and four (4.4 percent) nonadherent patients, and 30-day mortality occurred in four (4.3 percent) low-risk and 15 (10.7 percent) high-risk patients. In addition, 69.5 percent of high-risk patients were inappropriately administered vancomycin.

“Febrile neutropaenia is an oncologic emergency associated with significant morbidity and mortality,” according to the authors.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.